Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial-Reference-Cited by-同舟云学术

Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial

Published:2023-04 Issue:4 Volume:24 Page:371-382
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zhu Yujia,Wen Jing,Li Qiaoqiao,Chen Baoqing,Zhao Lei,Liu Shiliang,Yang Yadi,Wang Sifen,Lv Yingxin,Li Jibin,Zhang Li,Hu Yonghong,Liu Mengzhong,Xi Mian

Funder

Shanghai Junshi Biosciences

National Natural Science Foundation of China

Guangzhou Municipal Science and Technology Project

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial;Conroy;Lancet Oncol,2014

3. Comparison of 3 paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell cancer: a randomized clinical trial;Ai;JAMA Netw Open,2022

4. Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study);Hulshof;J Clin Oncol,2021

5. Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial;Liu;Nat Commun,2021

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023;Clinical Oncology;2024-09

2. The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study;Clinical and Translational Radiation Oncology;2024-09

3. Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial;eClinicalMedicine;2024-09

4. Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older;Radiation Oncology;2024-08-29

5. Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial;Nature Communications;2024-08-20